Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $62 at SVB Leerink
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts BHVN Hot Sheet
Price: $13.88 -5.51%
Rating Summary:
16 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
16 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
SVB Leerink analyst Marc Goodman lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $62.00 (from $67.00) while maintaining an Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biohaven Pharma (BHVN) PT Raised to $48 at Baird
- Tango Therapeutics Inc. (TNGX) PT Raised to $45 at Wedbush
- Biohaven Pharma (BHVN) January 17.5 calls active, share price up 23.9%
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
